WHO ICTRP trial

Difference in awkaening time of cisatracurium-related paralysis with different…

CTRI/2023/07/055639 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2023/07/055639
Public title Difference in awkaening time of cisatracurium-related paralysis with different doses of neostigmine
Scientific title Comparative study of different methods of administration of neostigmine to reduce the reversal time of cisatracurium-induced moderate neuromuscular blockade.
Primary sponsor ANSHU KUMARI
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: K402- Bilateral inguinal hernia, withoutobstruction or gangrene
Interventions Intervention1: neostigmine 60 mcg: Neostigmine 60mcg/kg with glycopyrolate 20 mcg/kg when the TOFc will be 3 and 0.9% saline when the TOFr will be 0.4 Intervention2: Neostigmine(60) and glycopyrolate(20)@ TOFc3: neostigmine 60mcg/kg with…
Registration date Jul 25, 2023
Target size 72
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations